Mortality associated with early changes in ARDS severity in COVID–19 patients – Insights from the PRoVENT–COVID study
Purpose We investigated changes in ARDS severity and associations with outcome in COVID–19 ARDS patients. Methods We compared outcomes in patients with ARDS classified as ‘mild’, ‘moderate’ or ‘severe’ at calendar day 1, and after reclassification at calendar day 2. The primary endpoint was 28–day...
Main Authors: | , , , , |
---|---|
Other Authors: | |
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2021
|